REFERENCES
- Freireich EJ: The management of acute leukemia. Can Med Assoc J 96:1605–1610, 1967
- Karpatkin M: Diagnosis and management of disseminated intravascular coagulation. Pediatr Clin North Am 18:23–38, 1971
- Hersh EM, Freireich EJ: Host defense mechanisms and their modification by cancer chemotherapy. In Busch H (Editor): Methods in Cancer Research. New York, Academic Press, Inc, 1968, vol 4, pp 355–451
- Brown LR, Dreizen S, Bodey GP: Effect of immunosuppression on the human oral flora. In Mergenhagen SE, Sherp HW (Editors): Comparative Immunology of the Oral Cavity. Washington, DC, US Government Printing Office, 1973, pp 204–220
- Baker RD: Leukopenia and therapy in leukemia as factors predisposing to fatal mycoses. Am J Clin Pathol 37:358–373, 1962
- Taylor CG, Alexander RE, Green WH, et al: Mucormycosis (phycomycosis) involving the maxilla. Oral Surg 27:806–822, 1969
- Dreizen S, Bodey GP, Brown LR: Opportunistic mucosa. gram-negative bacillary infections in leukemia: Oral manifestations during myelosuppression. Postgrad Med 55:133–139, Apr 1974
- Baker BR: Active-site directed irreversible inhibitors of dihydrofolate reductase. Ann NY Acad Sci 186: 214–226, 1971
- Dreizen S: Oral indications of the deficiency states. Postgrad Med 49:97–102, Jan 1971
- Tan C, Etcubanas E, Wollner N, et al: Adriamycin—an antitumor antibiotic in the treatment of neoplastic diseases. Cancer 32:9–17, 1973
- Cupps RE, Ahmann DL, Soule EH: Treatment of pulmonary metastatic disease with radiation therapy and adjuvant actinomycin D. Cancer 24:719–723, 1969
- Rosenthal S, Kaufman S: Vincristine neurotoxicity. Ann Intern Med 80:733–737, 1974
- Winkleman AC, Mancali EL: Toxic effects of cancer chemotherapy agents on the nervous system. In Brodsky I, Kahn SB, Moyer JH (Editors): Cancer Chemotherapy II. New York, Grune & Stratton, Inc, 1972, pp 231–237